Is There Any Progress in the Area of Treating Hair Loss?

Propecia (finasteride) and Rogaine (minoxidil) have earned their reputation for being the most effective treatments for male pattern baldness. Both of these medications have been approved by the FDA for treating hair loss as the only two at the moment. The most immediate candidate that might get an FDA approval for treating hair loss in men is dutasteride (Avodart). This drug is similar in its activity as well as in its side effects to finasteride and its clinical trials have been already completed but no reports have been submitted to public scrutiny yet. Since this medication has long been approved for treating benign prostate enlargement many hair loss patients buy Avodart online and use it instead of Propecia.

The second most promising development in the area of hair loss research is bimatoprost, a medication used to treat glaucoma, which has recently been approved by the FDA as Latisse for extending eyelashes. The preliminary human trials with bimatoprost on human scalp suggest that this medication can thicken and darken the existing hair and it can speed up its growth. And last but not least is Dermaroller, a small device that causes damage to the scalp, which is expected to induce new hair growth. Similar devices are already used to treat wrinkles or skin damages caused by acne. Trials on mice in the past have shown that damaged skin started producing new hair, though its color and texture were slightly different from the regular hair. Dermarollers are already available as cosmetic devices although no FDA approval was awarded to them for treating hair loss.